Pulmonx (LUNG) Cash from Operations (QoQ) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -110.05% |
| Jun 30, 2025 | 70.45% |
| Mar 31, 2025 | -95.93% |
| Dec 31, 2024 | 6.43% |
| Sep 30, 2024 | -24.03% |
| Jun 30, 2024 | 50.78% |
| Mar 31, 2024 | -40.42% |
| Dec 31, 2023 | 3.45% |
| Sep 30, 2023 | -10.13% |
| Jun 30, 2023 | 37.30% |
| Mar 31, 2023 | -28.49% |
| Dec 31, 2022 | 8.24% |
| Sep 30, 2022 | -11.74% |
| Jun 30, 2022 | 36.35% |
| Mar 31, 2022 | -40.43% |
| Dec 31, 2021 | -28.92% |
| Sep 30, 2021 | 34.65% |
| Jun 30, 2021 | -30.93% |
| Mar 31, 2021 | -33.57% |
| Dec 31, 2020 | -23.69% |
| Sep 30, 2020 | 23.75% |
| Jun 30, 2020 | 21.43% |
| Mar 31, 2020 | -182.34% |